131 related articles for article (PubMed ID: 7015638)
1. Serobiological differentiation between antischistosomal (Schistosoma mansoni) antisera.
Hamburger J; Ben-Sasson SA
Tropenmed Parasitol; 1981 Mar; 32(1):43-7. PubMed ID: 7015638
[TBL] [Abstract][Full Text] [Related]
2. Failure of anti-Fasciola antisera to induce antibody-dependent, eosinophil-mediated killing of Schistosoma mansoni schistosomula.
Hillyer GV; Richardson BA; Butterworth AE
J Parasitol; 1987 Aug; 73(4):774-7. PubMed ID: 3114465
[TBL] [Abstract][Full Text] [Related]
3. Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection.
James SL; Sher A; Lazdins JK; Meltzer MS
J Immunol; 1982 Apr; 128(4):1535-40. PubMed ID: 7061842
[TBL] [Abstract][Full Text] [Related]
4. Schistosoma mansoni: the immune response against cercarial glycocalyx.
Hussein AH; Kaddah MA; Hamadto HH; el-Hayawan IA; Strickland PT; Abubaker S; Shiff CJ
J Parasitol; 1997 Jun; 83(3):424-9. PubMed ID: 9194821
[TBL] [Abstract][Full Text] [Related]
5. Subclasses of rat IgG active in the killing of schistosomula of Schistosoma mansoni in vitro and in vivo.
Horta MF; Ramalho-Pinto FJ
J Immunol; 1984 Dec; 133(6):3326-32. PubMed ID: 6491290
[TBL] [Abstract][Full Text] [Related]
6. Decreased binding of cytotoxic antibody by developing Schistosoma mansoni. Evidence for a surface change independent of host antigen adsorption and membrane turnover.
Dean DA
J Parasitol; 1977 Jun; 63(3):418-26. PubMed ID: 325186
[TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer of protective immunity in experimental schistosomiasis in the mouse.
Maddison SE; Kagan IG
J Parasitol; 1979 Aug; 65(4):515-9. PubMed ID: 512748
[TBL] [Abstract][Full Text] [Related]
8. Studies on the surface antigenicity and susceptibility to antibody-dependent killing of developing schistosomula using sera from chronically infected mice and mice vaccinated with irradiated cercariae.
Bickle QD; Ford MJ
J Immunol; 1982 May; 128(5):2101-6. PubMed ID: 7061855
[TBL] [Abstract][Full Text] [Related]
9. Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils.
Anwar AR; Smithers SR; Kay AB
J Immunol; 1979 Feb; 122(2):628-37. PubMed ID: 762435
[No Abstract] [Full Text] [Related]
10. Immunoprecipitation analysis of radiolabelled protein antigens biosynthesized in vitro by S. mansoni. I. Identification of antigens uniquely recognized by protective antibodies.
Barker RH; Srivastava BS; Suri P; Goldberg M; Knopf PM
J Immunol; 1985 Feb; 134(2):1192-201. PubMed ID: 3965570
[TBL] [Abstract][Full Text] [Related]
11. Blocking activity of rat monoclonal antibodies in experimental schistosomiasis.
Grzych JM; Capron M; Dissous C; Capron A
J Immunol; 1984 Aug; 133(2):998-1004. PubMed ID: 6736654
[TBL] [Abstract][Full Text] [Related]
12. Bge snail cell-line antigens: ineffectiveness as antischistosomal vaccine in mice.
Stein PC; Basch PF
J Parasitol; 1979 Dec; 65(6):862-9. PubMed ID: 120433
[TBL] [Abstract][Full Text] [Related]
13. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
14. Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. II. In vitro killing of TNP-schistosomula by human eosinophils and neutrophils.
Moser G; Sher A
J Immunol; 1981 Mar; 126(3):1025-9. PubMed ID: 7462624
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma mansoni: in vitro and in vivo killing of antibody-coated schistosomula.
Correa-Oliveira R; Mota-Santos TA; Gazzinelli G
Am J Trop Med Hyg; 1982 Sep; 31(5):991-8. PubMed ID: 7125066
[TBL] [Abstract][Full Text] [Related]
16. A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum.
Mahmoud AA; Warren KS; Peters PA
J Exp Med; 1975 Oct; 142(4):805-13. PubMed ID: 1185104
[TBL] [Abstract][Full Text] [Related]
17. Macrophages as effector cells of protective immunity in murine schistosomiasis. III. Loss of susceptibility to macrophage-mediated killing during maturation of S. mansoni schistosomula from the skin to the lung stage.
Sher A; James SL; Simpson AJ; Lazdins JK; Meltzer MS
J Immunol; 1982 Apr; 128(4):1876-9. PubMed ID: 7061853
[TBL] [Abstract][Full Text] [Related]
18. Passive transfer of acquired resistance to Schistosoma mansoni in laboratory mice.
Sher A; Smithers SR; Mackenzie P
Parasitology; 1975 Jun; 70 Part 3():347-57. PubMed ID: 1134831
[TBL] [Abstract][Full Text] [Related]
19. Schistosoma mansoni in baboons. Antibody-dependent cell-mediated damage to 51Cr-labelled schistosomula.
Butterworth AE; Sturrock RF; Houba V; Taylor R
Clin Exp Immunol; 1976 Jul; 25(1):95-102. PubMed ID: 825338
[TBL] [Abstract][Full Text] [Related]
20. The acquisition of antigens in the intercellular substance of mouse skin by schistosomula of Schistosoma mansoni.
Smith HV; Kusel JR
Clin Exp Immunol; 1979 Jun; 36(3):430-5. PubMed ID: 385180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
